| Catalog No. | HT348011 |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
| Purity | >90% as determined by SDS-PAGE. |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | O14763 |
| Protein length | Met1-Glu182 |
| Nature | Recombinant |
| Predicted molecular weight | 46.35 kDa |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Reconstitution | Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details. |
| Alternative name | TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2 |
| Species | Homo sapiens (Human) |
| Shipping | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Note | For research use only. |
Recombinant Human CD262/TNFRSF10B/TRAIL-R2 Protein, C-Fc
Overview
Images
 SDS-PAGE |
SDS-PAGE for Recombinant Human CD262/TNFRSF10B/TRAIL-R2 Protein, C-Fc |
 Bioactivity |
Detects Tilogotamab in indirect ELISAs. |
 Bioactivity |
Detects Tigatuzumab in indirect ELISAs. |
 Bioactivity |
Detects Conatumumab in indirect ELISAs. |
 Bioactivity |
Detects Lexatumumab in indirect ELISAs. |